Skip to content

The Validity of the Use of Imaging in Cervical Cancer Staging

The Validity of the Use of Imaging in Cervical Cancer Staging

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06487767
Enrollment
100
Registered
2024-07-05
Start date
2024-07-01
Completion date
2026-12-31
Last updated
2024-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer Stage, Imaging Modalities

Keywords

Cervical cancer, Ultrasound, MRI, CT Scan, PET-CT scan

Brief summary

The study wil aim to investigate the accuracy of imaging in the staging of women diagnosed with cervical cancer

Detailed description

Patients with cervical cancer undergoing surgery will also undergo PET-CT scan, CT scan, trans-abdominal ultrasound of the pelvis and abdomen to assess pelvic and para-aortic lymph node status, MRI and trans-vaginal ultrasound (TVUS) to assess tumour size and parametrial infiltration. As per the current unit protocol, patients will be assessed clinically for operability. The performance of the different imaging modalities will be measured against the histological status of the parametric and lymph nodes and tumour size as measured by the pathologists. CT, PET-CT, MRI and abdominal ultrasound will be reported as per the usual departmental process. Staff in the radiology department will be blinded for the different imaging modalities performed. TVUS will be performed in the unit by different gynaecological oncologists and fellows and at the time of the investigation will be blinded with regards to clinical findings and the reports of other imaging studies performed. The sensitivity, specificity, positive and negative predictive values will be calculated for the different imaging modalities.

Interventions

OTHERSurgery

Surgery for operable cervical cancer

Sponsors

Dr Edwin Mnisi
CollaboratorUNKNOWN
Prof Mike Sathekge
CollaboratorUNKNOWN
Prof N Khan
CollaboratorUNKNOWN
University of Pretoria
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum

Inclusion criteria

\- Women diagnosed with cervical cancer Able and willing to provide informed consent

Exclusion criteria

Previously treated for cervical cancer Unable to provide informed consent Patients with contra-indications to undergo surgical treatment \-

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity and specificity2 yearsMetrics of imaging

Countries

South Africa

Contacts

Primary ContactEdwin F Mnisi, MMed (O&G)
edwinmnisi@hotmail.com+27766129797
Backup ContactLeon C Snyman, PhD
leon.snyman@up.ac.za+27834621818

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026